Quality · Access · Hope
Countries

🇦🇪 Country Profile

United Arab Emirates

Fast-growing pharmaceutical trade with United Arab Emirates

🇦🇪 $374M
All data from DGCIS India export records (fiscal year, April–March).
$374M
Scale
United Arab Emirates' healthcare system receives $374M in Indian pharmaceutical products each year — affordable, quality medicine.
55%
Medicine
Primarily medicines (55%), supplemented by medicine ingredients and traditional & herbal.
3.8×
Trajectory
One of the faster-growing relationships — India's pharmaceutical supply to United Arab Emirates has expanded 3.8× over the decade.
Context
Part of India's pharmaceutical supply network across Middle East.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in United Arab Emirates — building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix — FY 2025–26 DGCIS
Medicines $207M (55.4%) Medicine Ingredients $110M (29.5%) Traditional & Herbal $32.4M (8.7%) Surgical & Hospital Supplies $22.3M (6.0%) Vaccines $1.9M (0.5%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in United Arab Emirates Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into United Arab Emirates: $889M across 64 filings (2011-2026).